Show simple item record

dc.contributor.authorTse, Gary
dc.contributor.authorPrice, David
dc.contributor.authorBafadhel, Mona
dc.contributor.authorPapi, Alberto
dc.contributor.authorCarter, Victoria
dc.contributor.authorAriti, Cono
dc.contributor.authorZhou, Jiandong
dc.contributor.authorSkinner, Derek
dc.contributor.authorXu, Xiao
dc.contributor.authorMüllerová, Hana
dc.contributor.authorEmmanuel, Benjamin
dc.date.accessioned2023-11-30T00:11:52Z
dc.date.available2023-11-30T00:11:52Z
dc.date.issued2022-12-01
dc.identifier236865697
dc.identifierb7e84c58-b59e-4b5b-a889-4fcf04b9d063
dc.identifier.citationTse , G , Price , D , Bafadhel , M , Papi , A , Carter , V , Ariti , C , Zhou , J , Skinner , D , Xu , X , Müllerová , H & Emmanuel , B 2022 , ' Mortality outcomes associated with oral corticosteroid use in patients with COPD ' , European Respiratory Journal , vol. 60 , no. 66 , 1819 . https://doi.org/10.1183/13993003.congress-2022.1819en
dc.identifier.issn0903-1936
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19968
dc.descriptionResearch funding source: This study was supported by AstraZeneca.en
dc.format.extent1
dc.format.extent221176
dc.language.isoeng
dc.relation.ispartofEuropean Respiratory Journalen
dc.subjectCOPDen
dc.subjectCOPD – managementen
dc.subjectTreatmentsen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleMortality outcomes associated with oral corticosteroid use in patients with COPDen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1183/13993003.congress-2022.1819
dc.date.embargoedUntil2023-11-30
dc.identifier.vol60en
dc.identifier.iss66en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record